Abirami Financial Intrinsic Value
Abirami Financial (ABIRAFN) median intrinsic value is ₹11.40 from 5 valuation models (range ₹10–₹32), vs current price ₹33.00 — -65.5% downside (Trading Above Calculated Value), margin of safety -100.0%. For current market price and key ratios, visit ABIRAFN share price screener.
ABIRAFN Valuation Methods Summary — DCF, Graham Number & P/E
Abirami Financial intrinsic value across 5 models vs current price ₹33.00 — upside/downside and value range per method. Read ABIRAFN dividend track record for the complete payout history and dividend yield track record.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹11.40 | ₹9.12 - ₹13.68 | -65.5% | EPS: ₹0.95, Sector P/E: 12x |
| Book Value Method | asset | ₹32.00 | ₹28.80 - ₹35.20 | -3.0% | Book Value/Share: ₹40.00, P/B: 0.8x |
| PEG Ratio Method | growth | ₹9.90 | ₹8.91 - ₹10.89 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹9.90 | ₹8.91 - ₹10.89 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| Graham Defensive Method | conservative | ₹29.24 | ₹26.32 - ₹32.16 | -11.4% | EPS: ₹0.95, BVPS: ₹40.00 |
ABIRAFN Intrinsic Value vs Market Price — All Valuation Models
Abirami Financial fair value range ₹10–₹32 vs current market price ₹33.00 across 5 valuation models. Analyse Abirami Financial ownership structure to track promoter, FII and institutional holdings.
ABIRAFN Intrinsic Value Analysis — Undervalued or Overvalued?
Abirami Financial median intrinsic value ₹11.40, current price ₹33.00 — Trading Above Calculated Value by 65.5%, margin of safety -100.0%.
What is the intrinsic value of ABIRAFN?
Based on our comprehensive analysis using 5 different valuation methods, the estimated intrinsic value of Abirami Financial (ABIRAFN) is ₹11.40 (median value). With the current market price of ₹33.00, this represents a -65.5% variance from our estimated fair value.
The valuation range spans from ₹9.90 to ₹32.00, indicating ₹9.90 - ₹32.00.
Is ABIRAFN undervalued or overvalued?
Based on our multi-method analysis, Abirami Financial (ABIRAFN) appears to be trading above calculated value by approximately 65.5%.
ABIRAFN Financial Health — Key Ratios vs Industry Benchmarks
Abirami Financial financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | 5.0% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
ABIRAFN Cash Flow Quality — Operating & Free Cash Flow
Abirami Financial operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-6 Cr | ₹-6 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |